Nuveen Asset Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $351K | Hold |
66,114
| – | – | ﹤0.01% | 3091 |
|
|
2024
Q3 | $241K | Hold |
66,114
| – | – | ﹤0.01% | 3187 |
|
|
2024
Q2 | $180K | Buy |
+66,114
| New | +$180K | ﹤0.01% | 3235 |
|
|
2022
Q2 | – | Sell |
-762,027
| Closed | -$1.88M | – | 3428 |
|
|
2022
Q1 | $1.88M | Sell |
762,027
-17,941
| -2% | -$44.3K | ﹤0.01% | 2533 |
|
|
2021
Q4 | $3.13M | Sell |
779,968
-2,036
| -0.3% | -$8.16K | ﹤0.01% | 2356 |
|
|
2021
Q3 | $5.3M | Buy |
782,004
+418,085
| +115% | +$2.83M | ﹤0.01% | 2177 |
|
|
2021
Q2 | $3.59M | Buy |
363,919
+207,036
| +132% | +$2.04M | ﹤0.01% | 2412 |
|
|
2021
Q1 | $1.47M | Buy |
156,883
+15,134
| +11% | +$141K | ﹤0.01% | 2753 |
|
|
2020
Q4 | $681K | Buy |
141,749
+2,152
| +2% | +$10.3K | ﹤0.01% | 2937 |
|
|
2020
Q3 | $560K | Buy |
139,597
+749
| +0.5% | +$3.01K | ﹤0.01% | 2917 |
|
|
2020
Q2 | $637K | Buy |
138,848
+29,849
| +27% | +$137K | ﹤0.01% | 2808 |
|
|
2020
Q1 | $356K | Sell |
108,999
-96
| -0.1% | -$314 | ﹤0.01% | 2882 |
|
|
2019
Q4 | $470K | Sell |
109,095
-1,960
| -2% | -$8.44K | ﹤0.01% | 2917 |
|
|
2019
Q3 | $437K | Buy |
111,055
+12,267
| +12% | +$48.3K | ﹤0.01% | 2985 |
|
|
2019
Q2 | $460K | Buy |
+98,788
| New | +$460K | ﹤0.01% | 3022 |
|